That can't be a bad thing.” Xiaflex, based on a combination of several subtypes of collagenase enzyme derived from the bacterium Clostridium histolyticum, has completed a phase 3 trial in ...

MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled promising data from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in treating plantar fibromatosis, presented at ...

Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.

Sept. 13, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that data from a clinical study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis ...

Tuula Nylund, MD; Ville M. Mattila MD, PhD; Tapani Salmi MD, PhD; Harri K. Pihlajamäki, MD, PhD; Jyrki P. Mäkelä MD, PhD ...